Nepafenac Compared to Placebo for Ocular Pain and Inflammation

PHASE3CompletedINTERVENTIONAL

Enrollment

260

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Cataract

Interventions

DRUG

Nepafenac Ophthalmic Suspension, 0.1%

Topical ocular administration

OTHER

Nepafenac Vehicle Ophthalmic Solution

Inactive ingredients used as placebo; topical ocular administration

Trial Locations (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou